Concomitant beta-blocker use is associated with a reduced rate of remission in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs: a post hoc multicohort analysis.
Ahmad Y AbuhelwaDavid J R FosterArkady Manning-BennettMichael J SorichSusanna ProudmanMichael D WieseAshley M HopkinsPublished in: Therapeutic advances in musculoskeletal disease (2021)
In a large, pooled cohort of RA patients initiating csDMARDs and/or tocilizumab, BB use was independently associated with less frequent remission.
Keyphrases